BG60444B2 - Метод за получаване на избран протеин - Google Patents

Метод за получаване на избран протеин Download PDF

Info

Publication number
BG60444B2
BG60444B2 BG98458A BG9845894A BG60444B2 BG 60444 B2 BG60444 B2 BG 60444B2 BG 98458 A BG98458 A BG 98458A BG 9845894 A BG9845894 A BG 9845894A BG 60444 B2 BG60444 B2 BG 60444B2
Authority
BG
Bulgaria
Prior art keywords
protein
bacterial
polypeptide
gene
periplasmic
Prior art date
Application number
BG98458A
Other languages
Bulgarian (bg)
English (en)
Inventor
Walter Gilbert
Stephanie Broome
Lydia Villa-Komaroff
Argiris Efstratiadis
Original Assignee
President And Fellows Of Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25433372&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG60444(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by President And Fellows Of Harvard College filed Critical President And Fellows Of Harvard College
Publication of BG60444B2 publication Critical patent/BG60444B2/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/86—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides, e.g. penicillinase (3.5.2)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/034—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/30—Signal or leader sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BG98458A 1978-06-08 1994-02-11 Метод за получаване на избран протеин BG60444B2 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/913,533 US4411994A (en) 1978-06-08 1978-06-08 Protein synthesis

Publications (1)

Publication Number Publication Date
BG60444B2 true BG60444B2 (bg) 1995-03-31

Family

ID=25433372

Family Applications (1)

Application Number Title Priority Date Filing Date
BG98458A BG60444B2 (bg) 1978-06-08 1994-02-11 Метод за получаване на избран протеин

Country Status (20)

Country Link
US (1) US4411994A (fr)
EP (1) EP0006694B2 (fr)
JP (2) JPS5519092A (fr)
AT (1) ATE5001T1 (fr)
AU (1) AU524856B2 (fr)
BG (1) BG60444B2 (fr)
CA (1) CA1215920A (fr)
DD (1) DD148235A5 (fr)
DE (1) DE2966291D1 (fr)
DK (1) DK237979A (fr)
ES (1) ES481362A1 (fr)
FI (1) FI791841A (fr)
GR (1) GR72953B (fr)
IE (1) IE48156B1 (fr)
IL (1) IL57491A (fr)
MX (1) MX6339E (fr)
NZ (1) NZ190524A (fr)
PT (1) PT69737A (fr)
WO (1) WO1980000030A1 (fr)
ZA (1) ZA792486B (fr)

Families Citing this family (109)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2422717B1 (fr) * 1977-11-08 1985-12-06 Genentech Inc Procede permettant l'expression microbienne de polypeptides et moyens appropries
US6270955B1 (en) 1978-12-22 2001-08-07 Biogen, Inc. Pharmaceutical compositions and methods for producing antibodies to hepatitis b virus and kits and methods for detecting antibodies to hepatitis b virus
US4342832A (en) * 1979-07-05 1982-08-03 Genentech, Inc. Method of constructing a replicable cloning vehicle having quasi-synthetic genes
GR70279B (fr) * 1979-09-12 1982-09-03 Univ California
DE3001928A1 (de) * 1980-01-19 1981-08-06 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enthaltenden mikroorganismus
US6455275B1 (en) 1980-02-25 2002-09-24 The Trustees Of Columbia University In The City Of New York DNA construct for producing proteinaceous materials in eucaryotic cells
CA1200773A (fr) * 1980-02-29 1986-02-18 William J. Rutter Liens d'expression
AU545912B2 (en) * 1980-03-10 1985-08-08 Cetus Corporation Cloned heterologous jive products in bacillies
US4711843A (en) * 1980-12-31 1987-12-08 Cetus Corporation Method and vector organism for controlled accumulation of cloned heterologous gene products in Bacillus subtilis
IL62552A0 (en) 1980-04-03 1981-06-29 Biogen Nv Dna sequences,recombinant dna molecules and processes for producing human fibroblast interferon-like polypeptides
US4338397A (en) * 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis
US6610830B1 (en) 1980-07-01 2003-08-26 Hoffman-La Roche Inc. Microbial production of mature human leukocyte interferons
GR81946B (fr) * 1980-09-25 1984-12-12 Genentech Inc
US4394443A (en) * 1980-12-18 1983-07-19 Yale University Method for cloning genes
FI64813C (fi) * 1980-12-31 1984-01-10 Ilkka Antero Palva Foerfarande foer producering av ett utvalt aeggviteaemne och vid foerfarandet anvaenda rekombinantplasmidvektorer
NZ199391A (en) * 1981-01-02 1985-12-13 Genentech Inc Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin
DK582381A (da) * 1981-01-02 1982-07-03 Univ New York Remkombinat plasmid til anvendelse ved bakteriel kloning
US4663285A (en) * 1981-01-06 1987-05-05 The Public Health Laboratory Service Board Chimeric plasmids
ZA824218B (en) * 1981-06-29 1983-04-27 Cetus Corp Plasmid for producing human insulin
JPS5869897A (ja) * 1981-10-20 1983-04-26 Gakuzo Tamura Ｄｎａ遺伝子
EP0078154A3 (fr) * 1981-10-28 1985-01-09 The Regents Of The University Of California Plasmides et cellules pour l'expression hétérologue de métallothionéines, et procédés pour la production et l'utilisation de métallothionéine
US4532207A (en) * 1982-03-19 1985-07-30 G. D. Searle & Co. Process for the preparation of polypeptides utilizing a charged amino acid polymer and exopeptidase
US4863855A (en) * 1982-05-14 1989-09-05 The Research Foundation Of State University Of New York Novel cloning vehicles for polypeptide expression in microbial hosts
JPS592689A (ja) * 1982-06-04 1984-01-09 Handai Biseibutsubiyou Kenkyukai 強力な遺伝子発現能を有する新規レプリコンの作成法
US4595658A (en) * 1982-09-13 1986-06-17 The Rockefeller University Method for facilitating externalization of proteins synthesized in bacteria
DE3382547D1 (de) * 1983-01-12 1992-05-27 Chiron Corp Sekretorische expression in eukaryoten.
SE8300693L (sv) * 1983-02-09 1984-08-10 Sven Lofdahl Sett att framstella och isolera proteiner och polypeptider samt en hybridvektor for detta
US4962055A (en) * 1983-03-08 1990-10-09 Rikagaku Kenkyusho Plasmid, method for construction of the same, microorganisms carrying the plasmid and method for cultivation of the microorganism
DK138984A (da) * 1983-03-08 1984-09-09 Rikagaku Kenkyusho Plasmid, fremgangsmaade til fremstilling heraf, mikroorganismer indeholdende samme samt fremgangsmaade til dyrkning af mikroorganismen
JPS59162874A (ja) * 1983-03-08 1984-09-13 Rikagaku Kenkyusho 微生物の培養方法
US4711844A (en) * 1983-03-09 1987-12-08 Cetus Corporation Modified signal peptides
US4820642A (en) * 1983-04-04 1989-04-11 The Regents Of The University Of California Amplified expression vector
JPS60501140A (ja) * 1983-04-22 1985-07-25 アムジエン 酵母による外因性ポリペプチドの分泌
US7198919B1 (en) 1983-04-25 2007-04-03 Genentech, Inc. Use of alpha factor sequences in yeast expression systems
DE3486216T2 (de) * 1983-04-25 1994-02-17 Chiron Corp Hybrid-DNS-Synthesis von reifen insulinähnlichen Wachstumsfaktoren.
US4663280A (en) * 1983-05-19 1987-05-05 Public Health Research Institute Of The City Of New York Expression and secretion vectors and method of constructing vectors
GB8314362D0 (en) * 1983-05-24 1983-06-29 Celltech Ltd Polypeptide and protein products
IL71991A (en) * 1983-06-06 1994-05-30 Genentech Inc Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes
FR2549855B1 (fr) * 1983-07-29 1987-03-27 Grp Genie Genetique Sequence nucleotidique codant pour le peptide signal de la toxine diphterique, vecteur contenant cette sequence nucleotidique, leur application a la transformation de micro-organismes et compositions peptidiques obtenues
JPH0646946B2 (ja) * 1984-03-30 1994-06-22 三菱化成株式会社 蛋白の産生方法
US4695542A (en) 1983-10-04 1987-09-22 Dnax Research Institute Of Molecular And Cellular Biology, Inc. cDNA clones coding for polypeptides exhibiting multi-lineage cellular growth factor activity
NZ210501A (en) * 1983-12-13 1991-08-27 Kirin Amgen Inc Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
KR850004274A (ko) * 1983-12-13 1985-07-11 원본미기재 에리트로포이에틴의 제조방법
US4703008A (en) * 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
PH23920A (en) * 1983-12-20 1990-01-23 Cetus Corp Glucoamylase cdna
IT1185503B (it) * 1984-01-11 1987-11-12 Univ New York Cloni di odna di eritropietina umana
US4859465A (en) * 1984-04-20 1989-08-22 The Regents Of The University Of California Vaccine capable of eliciting multivalent antibodies
DK58285D0 (da) * 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
US5668255A (en) * 1984-06-07 1997-09-16 Seragen, Inc. Hybrid molecules having translocation region and cell-binding region
US6022950A (en) * 1984-06-07 2000-02-08 Seragen, Inc. Hybrid molecules having translocation region and cell-binding region
US4801537A (en) * 1984-06-08 1989-01-31 Genex Corporation Vector for expression of polypeptides in bacilli
US5672347A (en) * 1984-07-05 1997-09-30 Genentech, Inc. Tumor necrosis factor antagonists and their use
JPH062074B2 (ja) * 1984-07-27 1994-01-12 國男 山根 オリゴペプチドの製法
DE3587205T2 (de) * 1984-07-30 1993-08-26 Wakunaga Seiyaku Kk Verfahren zur herstellung eines proteins und dafuer zu verwendender vektor, rekombinante dns und transformierte zelle.
JP2524693B2 (ja) * 1984-07-30 1996-08-14 湧永製薬株式会社 蛋白質の製造法
JP2524695B2 (ja) * 1984-12-26 1996-08-14 湧永製薬株式会社 蛋白質の製造法
US5691181A (en) * 1984-08-21 1997-11-25 Celltech Limited DNA encoding lipase from human gastric mucosal tissue
JPS61268183A (ja) * 1985-05-24 1986-11-27 Wakamoto Pharmaceut Co Ltd Ｄｎａ，組換体ｄｎａおよびそれらを含む微生物
US5272254A (en) * 1984-10-02 1993-12-21 Biogen Inc. Production of streptavidin-like polypeptides
JP2624470B2 (ja) * 1984-10-02 1997-06-25 バイオジェン インコーポレイテッド ストレプトアビジン様ポリペプチドの製造
US4963495A (en) * 1984-10-05 1990-10-16 Genentech, Inc. Secretion of heterologous proteins
US5190874A (en) * 1984-12-28 1993-03-02 Rikagaku Kenkyusho Method for producing penicillinase and xylanase
JPH0817702B2 (ja) * 1984-12-28 1996-02-28 理化学研究所 新規プラスミド及びその調製方法並びにそのプラスミドを含有する新規微生物
US4774180A (en) * 1986-02-26 1988-09-27 Massachusetts Institute Of Technology Construction and application of polyproteins
JP2500311B2 (ja) * 1985-03-19 1996-05-29 工業技術院長 蛋白製造法
JP2620852B2 (ja) * 1985-07-30 1997-06-18 理化学研究所 新規プラスミド及びそれにより形質転換された新規微生物
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
USH2055H1 (en) 1985-09-20 2002-12-03 Zymogenetics, Inc. Expression of tissue-type plasminogen activator in bacteria
WO1987002037A1 (fr) * 1985-09-26 1987-04-09 Genetics Institute, Inc. Proteines tensio-actives pulmonaires
AU6408586A (en) * 1985-10-03 1987-04-24 Biotechnology Research Partners Limited Novel lipoprotein-based drug-delivery systems
JPH0669377B2 (ja) * 1985-11-25 1994-09-07 工業技術院長 Ｄｎａ塩基配列およびベクタ−
GB8529014D0 (en) * 1985-11-25 1986-01-02 Biogen Nv Enhanced secretion of heterologous proteins
CA1339757C (fr) * 1987-04-16 1998-03-17 Robert F. Halenbeck Methode de production bacteriologique de csf-1 humain recombinant biologiquement actif pur
US4929700A (en) * 1987-04-16 1990-05-29 Cetus Corporation Production of purified, biologically active, bacterially produced recombinant human CSF-1
US5084384A (en) * 1987-04-23 1992-01-28 Monsanto Company Secretion of insulin-like growth factor-I
US5426036A (en) * 1987-05-05 1995-06-20 Hoechst Aktiengesellschaft Processes for the preparation of foreign proteins in streptomycetes
US5066792A (en) * 1987-09-04 1991-11-19 Board Of Regents University Of Texas Gene probe for detection of specific human leukemias
EP0394409B1 (fr) 1988-09-02 1997-06-11 The Rockefeller University Mediateur inflammatoire derive de macrophages (mip-2)
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
FR2648713B1 (fr) * 1989-06-26 1994-06-10 Commissariat Energie Atomique Proteines hybrides entre une enzyme extracytoplasmique et une autre proteine, leur procede de preparation, ainsi que leur application comme agent de diagnostic
US7413537B2 (en) * 1989-09-01 2008-08-19 Dyax Corp. Directed evolution of disulfide-bonded micro-proteins
US5578464A (en) * 1989-10-31 1996-11-26 Schering Corporation E. coli secretory strains
US5595900A (en) * 1990-02-14 1997-01-21 The Regents Of The University Of Michigan Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
WO1992006191A1 (fr) * 1990-09-28 1992-04-16 Protein Engineering Corporation Agents d'elimination de la plaque dentaire a base de proteines
EP0575485A1 (fr) * 1991-03-01 1993-12-29 Dyax Corp. Procede de developpement de mini-proteines de liaison
EP0752853B1 (fr) 1993-03-10 2005-09-21 Smithkline Beecham Corporation Phosphodiesterase du cerveau humain
US5691180A (en) * 1994-06-09 1997-11-25 The Regents Of The University Of Michigan DNA sequence encoding N-acetyl-galactosamine-transferase
US5807732A (en) * 1995-02-28 1998-09-15 Lowe; John B. GDP-L-fucose: β-D-galactoside 2-α-L-fucosyltransferases, DNA sequences encoding the same, method for producing the same and a method of genotyping a person
US5770420A (en) * 1995-09-08 1998-06-23 The Regents Of The University Of Michigan Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
US6087128A (en) 1998-02-12 2000-07-11 Ndsu Research Foundation DNA encoding an avian E. coli iss
AU1223600A (en) 1998-10-28 2000-05-15 Genentech Inc. Process
WO2004097001A2 (fr) * 2003-04-29 2004-11-11 Genencor International, Inc. Nouvelle cellulase 029cel de bacille
CA2523722A1 (fr) * 2003-04-30 2004-11-18 Genencor International, Inc. Nouvelle cellulase bagcel de bacille
CN101374852B (zh) * 2003-04-30 2012-06-06 金克克国际有限公司 杆菌mHKcel纤维素酶
US7511005B2 (en) * 2003-05-12 2009-03-31 Danisco Us Inc., Genencor Division Lipolytic enzyme elip
EP1625208A4 (fr) * 2003-05-12 2006-10-18 Genencor Int Nouvelle enzyme lipolytique lip2
US20100129862A1 (en) 2003-05-12 2010-05-27 Jones Brian E Novel lipolytic Enzyme lip1
CN116018350A (zh) 2020-04-20 2023-04-25 韦斯塔隆公司 用于有害生物防治的蛋白水解稳定的U1-漏斗网蛛毒素-Ta1b变体多肽
JP2023524083A (ja) 2020-05-01 2023-06-08 ヴェスタロン・コーポレーション 殺虫剤の組み合わせ
CN116669558A (zh) 2020-09-28 2023-08-29 韦斯塔隆公司 用于害虫防治的mu-沙漠灌木蛛毒素-dc1a变体多肽
WO2022212863A1 (fr) 2021-04-01 2022-10-06 Vestaron Corporation Formulations de liposomes destinées à l'administration de pesticides et leurs procédés de production et d'utilisation
CA3215602A1 (fr) 2021-04-01 2022-10-06 Vestaron Corporation Polypeptides mutants av3 destines a la lutte antiparasitaire
AU2022398687A1 (en) 2021-11-29 2024-06-06 Ironwood Pharmaceuticals, Inc. Pharmaceutical compositions for the treatment of visceral pain
WO2023192924A1 (fr) 2022-03-30 2023-10-05 Vestaron Corporation Combinaisons de polypeptides mutants av3 et de toxines bt pour la lutte contre les organismes nuisibles
WO2023225555A1 (fr) 2022-05-18 2023-11-23 Vestaron Corporation Variants peptidiques d'actx pesticides
WO2023245169A1 (fr) 2022-06-17 2023-12-21 Vestaron Corporation Combinaisons de peptides antimicrobiens
WO2023245100A1 (fr) 2022-06-17 2023-12-21 Vestaron Corporation Peptides variants de ncr13 antimicrobiens
WO2023245128A1 (fr) 2022-06-17 2023-12-21 Vestaron Corporation Peptides antimicrobiens
WO2024026406A2 (fr) 2022-07-29 2024-02-01 Vestaron Corporation Peptides actx de nouvelle génération

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4082613A (en) * 1976-04-23 1978-04-04 The Regents Of The University Of Minnesota Process for the production of insulin by genetically transformed fungal cells
JPS53137215A (en) * 1977-05-06 1978-11-30 Harima Refractories Co Ltd Reparing material of blast oven gate by spray method
ES474852A1 (es) * 1977-11-08 1979-12-01 Genentech Inc Un metodo para la expresion,en un huesped bacteriano trans- formado de un polipeptido heterologo con respecto al huespeden su estado no transformado
AT373280B (de) * 1977-11-08 1984-01-10 Genentech Inc Verfahren zur erzeugung eines spezifischen polypeptids aus einem mikrobiellen rekombinations -clonbildungstraeger

Also Published As

Publication number Publication date
EP0006694A3 (en) 1980-01-23
IE48156B1 (en) 1984-10-17
ATE5001T1 (de) 1983-10-15
JPH0755151B2 (ja) 1995-06-14
AU524856B2 (en) 1982-10-07
IL57491A (en) 1983-09-30
AU4775279A (en) 1979-12-13
CA1215920A (fr) 1986-12-30
EP0006694A2 (fr) 1980-01-09
FI791841A (fi) 1979-12-09
MX6339E (es) 1985-04-23
JPS5519092A (en) 1980-02-09
GR72953B (fr) 1984-01-18
EP0006694B1 (fr) 1983-10-12
US4411994A (en) 1983-10-25
JPS6246160B2 (fr) 1987-09-30
JPS61227598A (ja) 1986-10-09
DE2966291D1 (en) 1983-11-17
EP0006694B2 (fr) 1992-01-22
DD148235A5 (de) 1981-05-13
NZ190524A (en) 1982-09-14
PT69737A (en) 1979-07-01
IL57491A0 (en) 1979-10-31
DK237979A (da) 1979-12-09
IE791115L (en) 1979-12-08
WO1980000030A1 (fr) 1980-01-10
ZA792486B (en) 1981-01-28
ES481362A1 (es) 1980-03-01

Similar Documents

Publication Publication Date Title
BG60444B2 (bg) Метод за получаване на избран протеин
US4565785A (en) Recombinant DNA molecule
US4782137A (en) Synthesis of protein with an identification peptide, and hybrid polypeptide incorporating same
US4703004A (en) Synthesis of protein with an identification peptide
EP0752886B1 (fr) Procede d'induction de reactions immunitaires contre les proteines endogenes a l'aide d'epitopes de lymphocytes t exogenes
JP2665359B2 (ja) 免疫親和性による精製方法
JP2512746B2 (ja) Ｂ型肝炎ウイルス抗原性を示すポリペプチドの製造方法
JP2573817B2 (ja) ヘテロポリマー系蛋白質の発現ベクターおよび該ベクターを含む細胞
IL86832A (en) A recombinant DNA molecule containing a nucleotide sequence of part of the region encoding HBV pre-1s, an immunogenic particle containing multiple peptide monomers containing a pre-s1 epitope and pharmaceutical preparations containing it
WO1989006283A1 (fr) Nouveau vecteur de plasmide avec sequence a fonction de signal pour pectate lyase
PT99313B (pt) Processo para a preparacao de proteinas, de viros recombinantes e de vectores de transferencia uteis para a expressao dessas proteinas
CN103224561A (zh) 葡萄球菌肠毒素小分子抗体及制备方法及用途
US4820642A (en) Amplified expression vector
KR100257574B1 (ko) 매독 트레포네마 융합 항원 및 그 융합 항원을 사용한 항매독 트레포네마 항체의 측정 방법
ES2331573T3 (es) Vector de expresion para la secrecion de un fragmento de anticuerpo usando una secuencia señal de e. coli y procedimiento para la produccion en serie del fragmento de anticuerpo.
JP2000503850A (ja) Ｓ―層―タンパク質の組み換え発現
KR840000949B1 (ko) 유전자 재조합 단백질의 제조방법
CN115010814B (zh) 一种诺如病毒p颗粒嵌合棘球蚴eg95蛋白的重组蛋白及其应用
CN111732667B (zh) 小反刍兽疫病毒基因工程亚单位疫苗
CN115947860A (zh) 一种重组人促卵泡生成素Fc融合蛋白及制备方法
CN116023448A (zh) 牛源化鼠抗布鲁氏杆菌抗体及其制备方法与应用
US20020182685A1 (en) In vivo generation of antibodies against antigens secreted in a host by transfected MEL cells
JPS63245691A (ja) ヒト免疫グロブリンＧＦｃ領域蛋白質およびその製造方法
JPS62201598A (ja) マウス−ヒトキメラ抗体ｈ鎖、それをコ−ドするキメラｄｎａ配列、プラスミドおよび細胞
CN106916223A (zh) 利用gst表达体系制备抗人pias3高效价抗体及应用